Updated treatment approach to hepatocellular carcinoma

Josep M. Llovet

doi:10.1007/s00535-005-1566-3

Article2021

Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines

Arndt Vogel, Erika Martinelli, Arndt Vogel, Andrés Cervantes, Ian Chau, Bruno Daniele, Josep M. Llovet, Tim Meyer, Jean‐Charles Nault, Ulf P. Neumann, Jens Ricke, Bruno Sangro, Peter Schirmacher, Chris Verslype, Francis Zech, Dirk Arnold, Erika Martinelli

Annals of Oncology

Article2004

Treatment of hepatocellular carcinoma

Josep M. Llovet

Current Treatment Options in Gastroenterology

Article2023

Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment

Josep M. Llovet, Catherine E. Willoughby, Amit G. Singal, Tim F. Greten, Mathias Heikenwälder, Hashem B. El–Serag, Richard S. Finn, Scott L. Friedman

Nature Reviews Gastroenterology & Hepatology

Article2002

Prognostic prediction and treatment strategy in hepatocellular carcinoma

Jordi Bruix, Josep M. Llovet

Hepatology

Article2005

ABLATIVE THERAPY FOR HEPATOCELLULAR CARCINOMA: EVIDENCE TO SUPPORT AN AGGRESSIVE INITIAL TREATMENT STRATEGY

M Sala, Josep M. Llovet, R. Vilana, Jordi Bruix, Jonathan M. Schwartz

Evidence-Based Gastroenterology

Updated treatment approach to hepatocellular carcinoma

Abstract

Discussion(0)

Related publications

Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines

Treatment of hepatocellular carcinoma

Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment

Prognostic prediction and treatment strategy in hepatocellular carcinoma

ABLATIVE THERAPY FOR HEPATOCELLULAR CARCINOMA: EVIDENCE TO SUPPORT AN AGGRESSIVE INITIAL TREATMENT STRATEGY